Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca to Double Stock Buyback as New Drugs Have Setbacks
AstraZeneca to Double Stock Buyback as New Drugs Have Setbacks
AstraZeneca to Double Stock Buyback as New Drugs Have Setbacks
Submitted by
admin
on January 27, 2011 - 8:52am
Source:
Bloomberg
News Tags:
stock buyback
AstraZeneca
Headline:
AstraZeneca to Double Stock Buyback as New Drugs Have Setbacks
Do Not Allow Advertisers to Use My Personal information
